2015
DOI: 10.1093/bioinformatics/btv183
|View full text |Cite
|
Sign up to set email alerts
|

Power and sample-size estimation for microbiome studies using pairwise distances and PERMANOVA

Abstract: We present a framework for PERMANOVA power estimation tailored to marker-gene microbiome studies that will be analyzed by pairwise distances, which includes: (i) a novel method for distance matrix simulation that permits modeling of within-group pairwise distances according to pre-specified population parameters; (ii) a method to incorporate effects of different sizes within the simulated distance matrix; (iii) a simulation-based method for estimating PERMANOVA power from simulated distance matrices; and (iv) … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
274
1
2

Year Published

2016
2016
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 328 publications
(281 citation statements)
references
References 24 publications
(25 reference statements)
4
274
1
2
Order By: Relevance
“…While sample size is always a valid concern, based on the microbiome-based power calculation, the current sample size is powered to detect a relatively large overall effect: 90 % power for an ω 2  = 0.04, unweighted UniFrac, an effect size similar to that of antibiotics [34]. Even at this small sample size, we were still able to identify significant microbiome differences between disease states and identify differential abundant taxa after multiple testing correction.…”
Section: Discussionmentioning
confidence: 99%
“…While sample size is always a valid concern, based on the microbiome-based power calculation, the current sample size is powered to detect a relatively large overall effect: 90 % power for an ω 2  = 0.04, unweighted UniFrac, an effect size similar to that of antibiotics [34]. Even at this small sample size, we were still able to identify significant microbiome differences between disease states and identify differential abundant taxa after multiple testing correction.…”
Section: Discussionmentioning
confidence: 99%
“…This is a proof-of-principle pilot study to develop a novel methodology for quantitation of clinically important bacterial species and antibiotic resistance genes from fecal samples in lieu of screening cultures. Samples from patients with presumed high and low risk for MDR bacteria were selected at a ratio of 1:2 with controls for a sample size of 90, which can achieve a power of Ͼ99% with deep sequencing in this study at a type 1 error rate of 0.03 for metagenome analysis using the HMP package in R with corrections using the Bonferroni method (22)(23)(24). As all patient samples were deidentified and no clinical information was obtained in association with any sample, institutional board review and informed consent were not required.…”
Section: Methodsmentioning
confidence: 99%
“…These include the effect size [measure of observed differences caused by the factor(s)], the DNA sequencing depth, the level of taxonomical description, the choice of the test statistics, the critical value for the type I error probability, the method of multiple comparison correction, and the sample size (Hair et al, 2010;La Rosa et al, 2015). The dependence of power on some of these parameters is presented in Jonsson et al (2016), Kelly et al (2015) and La Rosa et al (2015). The dependence on sample size is especially important for metagenomic studies, as the high cost of sequencing is very restrictive.…”
Section: Basic Stepsmentioning
confidence: 99%
“…The latter parameter can be determined during a pilot experiment (when a small subgroup of metagenomes is sequenced) or from published data revealing typical effect sizes in similar experiments (such as Kelly et al, 2015;La Rosa et al, 2015). It is worth noting that it can possibly be overestimated in experiments with a small sample size (Button et al, 2013).…”
Section: Basic Stepsmentioning
confidence: 99%
See 1 more Smart Citation